K L A-Tencor Corp (KLAC) 72.67 $KLAC How KLA-Tencor

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 9:11 AM

K L A-Tencor Corp (KLAC) 72.67 $KLAC

How KLA-Tencor (KLAC) Stock Stands Out in a Strong Industry
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:48AM CDT
KLA-Tencor (KLAC) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
KLAC: 72.67 (-0.74)

Kla-Tencor Rises 1.39% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri May 27, 2:21PM CDT
Kla-Tencor (NASDAQ:KLAC) traded in a range yesterday that spanned from a low of $71.91 to a high of $73.14. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $71.99 on volume of 224,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
KLAC: 72.67 (-0.74)

Look for Shares of Kla-Tencor to Potentially Pullback after Yesterday's 1.39% Rise
Comtex SmarTrend(R) - Fri May 27, 2:20PM CDT
Kla-Tencor (NASDAQ:KLAC) traded in a range yesterday that spanned from a low of $71.91 to a high of $73.14. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $71.99 on volume of 224,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
KLAC: 72.67 (-0.74)

Lam Research Prices Senior Notes, Gets Moody's Baa1Rating
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:25AM CDT
Lam Research Corporation (LRCX) recently announced the pricing of senior notes aggregating $2.4 billion.
LRCX: 82.37 (-1.26), AMAT: 24.07 (-0.35), KLAC: 72.67 (-0.74), AEIS: 38.22 (-0.63)

KLA-Tencor (KLAC) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:20AM CDT
KLA-Tencor Corporation (KLAC) has been struggling lately, but the selling pressure may be coming to an end soon
KLAC: 72.67 (-0.74)

SmarTrend Watching for Potential Rebound in Shares of Kla-Tencor After 1.41% Loss
Comtex SmarTrend(R) - Mon May 16, 1:37PM CDT
Kla-Tencor (NASDAQ:KLAC) traded in a range yesterday that spanned from a low of $67.32 to a high of $68.12. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $68.44 on volume of 1.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
KLAC: 72.67 (-0.74)

Kla-Tencor Falls 1.41% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon May 16, 1:35PM CDT
Kla-Tencor (NASDAQ:KLAC) traded in a range yesterday that spanned from a low of $67.32 to a high of $68.12. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $68.44 on volume of 1.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
KLAC: 72.67 (-0.74)

KLA-Tencor Declares Regular Cash Dividend For The Fourth Quarter Of Fiscal Year 2016
PR Newswire - Thu May 05, 3:15PM CDT
KLA-Tencor Corporation (NASDAQ: KLAC) today announced that its board of directors has declared a quarterly cash dividend of $.52 per share on its common stock payable on June 1, 2016 to KLA-Tencor stockholders of record as of the close of business on May 16, 2016.
KLAC: 72.67 (-0.74)

The Zacks Analyst Blog Highlights: Darden Restaurants, KLA-Tencor, Hasbro, Campbell Soup and American Tower
Zacks Equity Research - Zacks Investment Research - Wed May 04, 8:30AM CDT
The Zacks Analyst Blog Highlights: Darden Restaurants, KLA-Tencor, Hasbro, Campbell Soup and American Tower
HAS: 85.92 (-1.15), AMT: 108.79 (-0.28), CPB: 62.70 (+0.19), KLAC: 72.67 (-0.74), DRI: 67.81 (-0.52)

5 Strong Buy Dividend Stocks to Beat Sell-in-May Blues
Zacks Equity Research - Zacks Investment Research - Tue May 03, 7:45AM CDT
As more volatility is in the cards and the economic outlook remains unstable, it is time to add top-notch dividend stocks.
HAS: 85.92 (-1.15), GILD: 84.45 (-1.32), IBM: 152.37 (-1.05), AMT: 108.79 (-0.28), CPB: 62.70 (+0.19), KLAC: 72.67 (-0.74), MSFT: 51.48 (-0.14), AAPL: 98.83 (-0.82), DRI: 67.81 (-0.52)

CyberOptics Reports Strong First Quarter Sales Growth and Earnings
BusinessWire - Thu Apr 28, 3:00PM CDT
CyberOptics Corporation (Nasdaq: CYBE) today reported operating results for the first quarter of 2016 ended March 31.
NDSN: 84.88 (-2.08), KLAC: 72.67 (-0.74), CYBE: 16.42 (-0.55)

KLA Tops Q3 Earnings Estimates, Shareholders Approve Merger
Sejuti Banerjea - Zacks Investment Research - Wed Apr 27, 3:41PM CDT
KLA-Tencor Corporation (KLAC) reported third-quarter 2016 earnings of $1.15 cents a share, topping the Zacks Consensus Estimate of $1.00 cents by 15.0%.
AMD: 4.32 (-0.20), TSM: 25.86 (-0.37), KLAC: 72.67 (-0.74), MLNX: 48.38 (-1.81), SIMO: 44.31 (-1.30)

KLA-Tencor Reports Fiscal 2016 Third Quarter Results
PR Newswire - Tue Apr 26, 3:15PM CDT
KLA-Tencor Corporation (NASDAQ: KLAC) today announced operating results for its third quarter of fiscal year 2016, which ended on March 31, 2016, reporting GAAP net income of $176 million and GAAP earnings per diluted share of $1.12 on revenues of $712 million.
KLAC: 72.67 (-0.74)

Lam Research (LRCX) Q3 Earnings Beat, Revenues Miss
Zacks Equity Research - Zacks Investment Research - Thu Apr 21, 12:33PM CDT
Lam Research Corporation (LRCX) reported third quarter fiscal 2016 non-GAAP earnings of $1.18 per share, surpassing the Zacks Consensus Estimate by 8 cents.
LRCX: 82.37 (-1.26), KLAC: 72.67 (-0.74), ASML: 97.38 (-3.17), FEIC: 106.75 (-0.48)

Semiconductor Market in Vietnam Up 14.3% by 2019 - SEMICON Southeast Asia to Explore the Issues
JCN Newswire - Thu Apr 07, 3:40AM CDT
PENANG, Malaysia, Apr 7, 2016 - (ACN Newswire) - With the semiconductor industry in Vietnam expected to grow at a compound annual growth rate (CAGR) of 14.3% over the period of 2014 to 2019, momentum is growing in this emerging market. The electronics supply chain will convene at SEMICON Southeast Asia (SEA) from 26-28 April at the Subterranean Penang International Convention and Exhibition Centre (SPICE) in Penang, Malaysia to explore new opportunities and technology.
LRCX: 82.37 (-1.26), AMAT: 24.07 (-0.35), KLAC: 72.67 (-0.74)

Why KLA-Tencor (KLAC) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 7:49AM CDT
KLA-Tencor (KLAC) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
KLAC: 72.67 (-0.74)

3 Attractive Income Stocks Whose Dividends Could Double
Sean Williams, The Motley Fool - Motley Fool - Tue Mar 15, 7:19AM CDT
Image source: Pixabay. Dividend stocks can be the foundation of a great retirement portfolio. Not only do the payments put money in your pocket, which can help hedge against any dips in the stock market, they're usually a sign of a financially...
DFS: 56.30 (-0.50), V: 80.18 (-1.08), AXP: 64.97 (-0.74), LRCX: 82.37 (-1.26), FCAU: 6.87 (-0.28), KLAC: 72.67 (-0.74), MA: 95.21 (-1.81)

Kla-Tencor Set to Possibly Pullback After Yesterday's Rally of 1.30%
Comtex SmarTrend(R) - Fri Feb 19, 4:32PM CST
Kla-Tencor (NASDAQ:KLAC) traded in a range yesterday that spanned from a low of $65.59 to a high of $66.67. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $65.69 on volume of 5.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
KLAC: 72.67 (-0.74)

Lam Research Stockholders and KLA-Tencor Stockholders Approve Acquisition of KLA-Tencor by Lam Research
PR Newswire - Fri Feb 19, 11:01AM CST
Lam Research Corporation (Nasdaq: LRCX) and KLA-Tencor Corporation (Nasdaq: KLAC) today announced that matters presented at the respective meetings of the Lam Research stockholders and the KLA-Tencor stockholders held on February 19, 2016 relating to the October 20, 2015 merger agreement were approved. Lam Research stockholders approved the issuance of shares required to complete the acquisition of KLA-Tencor, and KLA-Tencor stockholders approved the adoption of the merger agreement.
LRCX: 82.37 (-1.26), KLAC: 72.67 (-0.74)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...